TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $24,000 | -52.0% | 4,300 | -65.9% | 0.01% | -62.5% |
| Q4 2018 | $50,000 | -60.0% | 12,600 | +32.6% | 0.02% | -42.9% |
| Q2 2018 | $125,000 | -7.4% | 9,500 | -1.0% | 0.03% | -15.2% |
| Q1 2018 | $135,000 | +419.2% | 9,600 | +200.0% | 0.03% | +450.0% |
| Q4 2017 | $26,000 | +225.0% | 3,200 | +300.0% | 0.01% | +500.0% |
| Q2 2017 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |